Some experiments have shown that farnesyltransferase inhibitor drugs, which prevent the post-translation processing of KRAS, essential for its appropriate cell-membrane localization, sensitize KRAS-mutated pancreatic cancer cells to radiation49. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.